GUJARAT KIDNEY AND SUPER SPECIALITY Financial Statement Analysis
|
||
|
The Revenues of GUJARAT KIDNEY AND SUPER SPECIALITY have increased by 103.80% YoY .
The Earnings Per Share (EPS) of GUJARAT KIDNEY AND SUPER SPECIALITY has increased by 18.67 % YoY. |
||
GUJARAT KIDNEY AND SUPER SPECIALITY Last 5 Annual Financial Results
[BOM: 544666|NSE : GKSL]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Operating Income | ₹82 Cr | ₹40 Cr | ₹4.77 Cr | ₹0.00 Cr | ₹0.00 Cr |
| Expenses | ₹55 Cr | ₹24 Cr | ₹2.82 Cr | ₹0.01 Cr | ₹0.08 Cr |
| Operating Profit (Excl OI) | ₹27 Cr | ₹17 Cr | ₹1.95 Cr | ₹-0.01 Cr | ₹-0.08 Cr |
| Other Income | ₹0.87 Cr | ₹0.16 Cr | ₹0.70 Cr | ₹0.00 Cr | ₹0.79 Cr |
| Interest | ₹1.88 Cr | ₹0.65 Cr | ₹0.07 Cr | ₹0.00 Cr | ₹0.00 Cr |
| Depreciation | ₹4.70 Cr | ₹3.29 Cr | ₹0.32 Cr | ₹0.00 Cr | ₹0.57 Cr |
| Profit Before Tax | ₹21 Cr | ₹13 Cr | ₹2.27 Cr | ₹-0.01 Cr | ₹0.14 Cr |
| Profit After Tax | ₹17 Cr | ₹9.50 Cr | ₹1.71 Cr | ₹-0.01 Cr | ₹0.10 Cr |
| Consolidated Net Profit | ₹15 Cr | ₹9.41 Cr | ₹1.71 Cr | ₹-0.01 Cr | ₹0.10 Cr |
| Earnings Per Share (Rs) | ₹1.97 | ₹1.66 | ₹85.70 | ₹-0.31 | ₹5.00 |
| PAT Margin (%) | 20.50 | 23.61 | 35.90 | 0.00 | 0.00 |
| ROE(%) | 12.08 | 68.65 | 162.40 | -1.66 | 26.56 |
| ROCE(%) | 15.51 | 63.02 | 35.61 | -1.66 | 36.31 |
| Total Debt/Equity(x) | 0.06 | 0.15 | 1.12 | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 1,230.5 Cr |
| Revenue (TTM) | : | ₹ 126.2 Cr |
| Net Profit(TTM) | : | ₹ 20.5 Cr |
| EPS (TTM) | : | ₹ 2.6 |
| P/E (TTM) | : | 60.2 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| GUJARAT KIDNEY AND SUPER SPECIALITY | -1.9% | -19.6% | NA |
| APOLLO HOSPITALS ENTERPRISE | 1.3% | 9% | 13% |
| MAX HEALTHCARE INSTITUTE | 2.2% | 10.8% | -14% |
| FORTIS HEALTHCARE | -1.1% | 2.1% | -23.4% |
| ASTER DM HEALTHCARE | -3.8% | 6.9% | 8.1% |
| NARAYANA HRUDAYALAYA | -3.1% | 10.2% | 1.4% |
| GLOBAL HEALTH | 4% | 13.6% | 21.8% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES | -0.7% | 5% | 3.4% |
| DR LAL PATHLABS | -0.9% | 2.8% | 30% |
GUJARAT KIDNEY AND SUPER SPECIALITY Revenues
[BOM: 544666|NSE : GKSL]
| Y-o-Y | 103.80 % |
| 5 Yr CAGR | 0 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹82 Cr | 103.80 | |
| Mar2025 | ₹40 Cr | 742.94 | |
| Mar2024 | ₹4.77 Cr | 0 | |
| Mar2023 | ₹0.00 Cr | 0 | |
| Mar2022 | ₹0.00 Cr | - | |
GUJARAT KIDNEY AND SUPER SPECIALITY Operating Profit
[BOM: 544666|NSE : GKSL]
| Y-o-Y | 62.81 % |
| 5 Yr CAGR | Positive |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹27 Cr | 62.81 | |
| Mar2025 | ₹17 Cr | 748.13 | |
| Mar2024 | ₹1.95 Cr | Positive | |
| Mar2023 | ₹-0.01 Cr | Negative | |
| Mar2022 | ₹-0.08 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -20.11 % |
| 5 Yr CAGR | 0 |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 32.85% | -20.11 | |
| Mar2025 | 41.12% | 0.61 | |
| Mar2024 | 40.87% | 0 | |
| Mar2023 | 0% | 0 | |
| Mar2022 | 0% | - | |
GUJARAT KIDNEY AND SUPER SPECIALITY Profit After Tax
[BOM: 544666|NSE : GKSL]
| Y-o-Y | 64.63 % |
| 5 Yr CAGR | 252.83 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹15 Cr | 64.63 | |
| Mar2025 | ₹9.41 Cr | 449.18 | |
| Mar2024 | ₹1.71 Cr | Positive | |
| Mar2023 | ₹-0.01 Cr | Negative | |
| Mar2022 | ₹0.10 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -13.17 % |
| 5 Yr CAGR | 0 |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 20.5 % | -13.17 | |
| Mar2025 | 23.61 % | -34.23 | |
| Mar2024 | 35.9 % | 0 | |
| Mar2023 | 0 % | 0 | |
| Mar2022 | 0 % | - | |
GUJARAT KIDNEY AND SUPER SPECIALITY Earnings Per Share (EPS)
[BOM: 544666|NSE : GKSL]
| Y-o-Y | 18.67 % |
| 5 Yr CAGR | -20.77 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹1.97 | 18.67 | |
| Mar2025 | ₹1.66 | -98.06 | |
| Mar2024 | ₹86 | Positive | |
| Mar2023 | ₹-0.31 | Negative | |
| Mar2022 | ₹5.00 | - | |
GUJARAT KIDNEY AND SUPER SPECIALITY Return on Capital Employed (ROCE)
[BOM: 544666|NSE : GKSL]
| Y-o-Y | -75.39 % |
| 5 Yr CAGR | -19.16 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 15.51% | -75.39 | |
| Mar2025 | 63.02% | 76.97 | |
| Mar2024 | 35.61% | Positive | |
| Mar2023 | -1.66% | Negative | |
| Mar2022 | 36.31% | - | |
GUJARAT KIDNEY AND SUPER SPECIALITY Share Price vs Sensex
| Current Share Price | : | ₹156.2 |
| Current MarketCap | : | ₹ 1,230.5 Cr |
| Updated EOD on | : | Nov 13,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT KIDNEY AND SUPER SPECIALITY | -1.9% |
-19.6% |
|
| SENSEX | 0.7% |
11.7% |
-2% |
GUJARAT KIDNEY AND SUPER SPECIALITY related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE IPO | 4.6% | 5.4% | 22.9% |
| BSE HEALTHCARE | 2.4% | 8.4% | 19.2% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY IPO INDEX | 4.1% | 2.4% | 16.6% |
You may also like the below Video Courses
FAQ about GUJARAT KIDNEY AND SUPER SPECIALITY Financials
How the annual revenues of GUJARAT KIDNEY AND SUPER SPECIALITY have changed ?
The Revenues of GUJARAT KIDNEY AND SUPER SPECIALITY have increased by 103.80% YoY .
How the Earnings per Share (EPS) of GUJARAT KIDNEY AND SUPER SPECIALITY have changed?
The Earnings Per Share (EPS) of GUJARAT KIDNEY AND SUPER SPECIALITY has increased by 18.67 % YoY .
Check out Intrinsic Value of Peers of GUJARAT KIDNEY AND SUPER SPECIALITY
Compare Stock Analytics of Peers of GUJARAT KIDNEY AND SUPER SPECIALITY
APOLLO HOSPITALS ENTERPRISE LTD vs MAX HEALTHCARE INSTITUTE LTD vs FORTIS HEALTHCARE LTD
ASTER DM HEALTHCARE LTD vs NARAYANA HRUDAYALAYA LTD vs
APOLLO HOSPITALS ENTERPRISE LTD vs MAX HEALTHCARE INSTITUTE LTD vs FORTIS HEALTHCARE LTD
ASTER DM HEALTHCARE LTD vs NARAYANA HRUDAYALAYA LTD vs
